OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
優化藥品的股票在公司報告了低於預期的第三季度銷售業績併發布了低於預估的2024財年銷售指引後交易下跌。
OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.
優化藥品的股票在公司報告了低於預期的第三季度銷售業績併發布了低於預估的2024財年銷售指引後交易下跌。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間